With T's crossed and I's dotted, CDMO Patheon has closed its $255 million acquisition of Banner Pharmacaps, maker of gelatin-based dosage forms. Banner is the world's second-largest softgel producer, and Patheon says the deal will make it a leader in oral dosage development and manufacturing, and push it toward the $1 billion annual revenue mark. Release